AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript
Seeking Alpha8/10/2026Neutral
AIRS
Airsculpt Technologies IncNASDAQHEALTHCAREMEDICAL CARE FACILITIES
Key Statistics
Market Cap
$222.41M
P/E Ratio
—
EPS
$-0.16
Beta
2.37
52W High
$12.00
52W Low
$1.51
50-Day MA
$4.56
200-Day MA
$3.71
Dividend Yield
—
Profit Margin
-7.79%
Forward P/E
—
PEG Ratio
—
About Airsculpt Technologies Inc
Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, specializing in its proprietary AirSculpt® procedure, which sets a new standard for minimally invasive body contouring while prioritizing patient safety and comfort. The company is aggressively expanding its network of licensed practitioners and utilizing innovative technologies to solidify its competitive advantage in the rapidly growing non-invasive cosmetic treatment market. With rising global demand for aesthetic solutions, Airsculpt is well-positioned to capture market share and broaden its service offerings, driving robust growth and long-term value for its investors.
Fundamentals
| Revenue (TTM) | $150.72M |
| Gross Profit (TTM) | $99.93M |
| EBITDA | $6.29M |
| Operating Margin | -0.07% |
| Return on Equity | -12.00% |
| Return on Assets | -1.91% |
| Revenue/Share (TTM) | $2.28 |
| Book Value | $1.47 |
| Price-to-Book | 2.36 |
| Price-to-Sales (TTM) | 1.48 |
| EV/Revenue | 1.983 |
| EV/EBITDA | 267.32 |
| Quarterly Earnings Growth (YoY) | 200.00% |
| Quarterly Revenue Growth (YoY) | -2.50% |
| Shares Outstanding | $72.09M |
| Float | $16.77M |
| % Insiders | 42.14% |
| % Institutions | 63.37% |
Historical Volatility
HV 10-Day
75.10%
HV 20-Day
65.17%
HV 30-Day
58.82%
HV 60-Day
66.36%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($4.50 target)
1
Strong Buy2
HoldLatest News
AirSculpt Technologies Q2 Earnings Call Highlights
AirSculpt Technologies NASDAQ: AIRS reported second-quarter revenue of $42.9 million, down 2.5% from the prior-year period, as the company cited stable revenue trends, positive same-center case growth and continued investment in marketing and expanded procedure offerings.
MarketBeat8/10/2026Positive
AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results
MIAMI BEACH, Fla., Aug. 10, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the second quarter ended June 30, 2026.
GlobeNewsWire8/10/2026Neutral
AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal 2026 Results
Company to Participate in Canaccord Genuity's 46th Annual Growth Conference Company to Participate in Canaccord Genuity's 46th Annual Growth Conference
GlobeNewsWire8/3/2026Neutral
AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions
HONG KONG & SEOUL, South Korea--(BUSINESS WIRE)--AIRS Medical (“the Company”), a global leader in AI solutions for medical imaging, today announced a strategic growth investment from TA Associates (“TA”), a leading global private equity firm. The investment will help fuel AIRS Medical's next phase of global expansion, advancement of its AI-powered radiology technology solutions and ongoing product innovation. Founded in 2018, AIRS Medical develops AI-native magnetic resonance imaging (“MRI”) ac.
Business Wire6/16/2026Neutral
AirSculpt Technologies Announces Participation in Upcoming Investor Conferences
MIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences.
GlobeNewsWire5/27/2026Neutral
AirSculpt Technologies, Inc. (AIRS) Shareholder/Analyst Call Prepared Remarks Transcript
AirSculpt Technologies, Inc. (AIRS) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha5/12/2026Neutral
AirSculpt Technologies Q1 Earnings Call Highlights
AirSculpt Technologies NASDAQ: AIRS reported first-quarter fiscal 2026 results that management characterized as a “key turning point,” citing stabilized revenue, the first positive same-center sales result in more than two years, and continued debt reduction. Get AirSculpt Technologies alerts:Sign UpQ1 results: flat revenue, positive same-center sales, and margin expansion Chief Executive Officer Yogi Jashnani said the company “stabilized revenue year-over-year and delivered positive same-center sales for the first time in over two years,” while also expanding gross margin.
MarketBeat5/8/2026Positive
AirSculpt Technologies, Inc. (AIRS) Q1 2026 Earnings Call Transcript
AirSculpt Technologies, Inc. (AIRS) Q1 2026 Earnings Call Transcript
Seeking Alpha5/8/2026Neutral
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results
MIAMI BEACH, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2026.
GlobeNewsWire5/8/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AIRS and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 8/18/2026